AbbVie Inc. - Feb 11, 2025 Form SCHEDULE 13G Schedule Report for Xilio Therapeutics, Inc. (XLO)

Filing Manager: AbbVie Inc.
Reporting Manager: AbbVie Inc.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 48.3M shares
Disclosed Ownership: 4.35M shares
Ownership: 9%
Form type: SCHEDULE 13G
Date filed: 2/18/2025, 04:15 PM
Date of event: Feb 11, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AbbVie Inc.	9%	4.35M	4.35M	0	/s/ Scott T. Reents	Scott T. Reents, Executive Vice President, Chief Financial Officer